Addiction Treatment Market

Addiction is a chronic condition which gives rise to psychological and physical damage. People who suffer from an addiction have an uncontrollable desire and lack of resistance to use lethal substances or to involve in harmful activities in spite of knowing their negative effects on their lives. Indications of addiction differ from person to person. Some have serious symptoms, such as inability to stop using addictive substance, increased tolerance for such addictive substance, lack of control as well as physical and emotional withdrawal. Risk of developing an addiction can be minimized by avoiding illegal drugs and immediately looking for counselling in case of any mental health disorder. A person suffering from an addictive disorder needs access to treatment. In many cases treatment may continue for the rest of their life. As per the patient’s need, treatment plans for addictive disorders will frequently modify. Treatment options  depend on various factors such as the type of addictive disorder, the duration and danger of use, and its impact on the individual.

According to the National Survey on Drug Use and Health, in the U.S., approximately 8.1 percent of the population need or undergo treatment for drug addiction.

Market Dynamics

The rising prevalence of addicted population, expanding drug product pipeline, and active involvement of generic manufacturers to provide cheaper drugs are the major factors that are expected to drive the growth of the global addiction treatment market over the forecast period.

For instance, manufacturers such as Insys Therapeutics (innovative Buprenorphine / Naloxone sublingual spray), BioCorRx, Inc. (Naltrexone Implant (BICX102)) have novel products in their pipeline for opioid and alcohol addiction treatment.

Key features of the study:

• This report provides an in-depth analysis of the global addiction treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global addiction treatment market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Alkremes Plc., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals, Titan Pharmaceuticals, Inc., Pfizer, Inc., GlaxoSmithKline plc., Johnson & Johnson, Perrigo Company plc., Cipla Limited, Hikma Pharmaceuticals Plc., Dr. Reddy’s Laboratories Limited, Indivior Inc., and Mylan N.V.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global addiction treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global addiction treatment market

Detailed Segmentation:

• Global Addiction Treatment Market, By Drug Type:

• • Opioid Addiction
    • Methadone
    • Buprenorphine
    • Naltrexone
  • Alcohol Addiction
    • Acamprosate
    • Disulfiram
    • Naltrexone
    • Others
  • Nicotine Replacement Therapies
    • Nicotine Gums
    • Nicotine Patches
    • Nicotine Lozenges
    • Nicotine Spray
    • Nicotine Inhaler
    • Nicotine Sublingual Tablets
  • Non-Nicotine Medication
    • Varenicline
    • Bupropion (Zyban)
• Global Addiction Treatment Market, By Region:
  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Alkremes Plc.*
    • Company Overview
    • Material Portfolio
    • Financial Performance
    • Key Highlights
    • Market Strategies
  • Teva Pharmaceutical Industries Ltd.
  • Glenmark Pharmaceuticals
  • Titan Pharmaceuticals, Inc.
  • Pfizer, Inc.
  • GlaxoSmithKline plc.
  • Johnson & Johnson
  • Perrigo Company plc.
  • Cipla Limited
  • Hikma Pharmaceuticals Plc.
  • Dr. Reddy’s Laboratories Limited
  • Indivior Inc.
  • Mylan N.V.

 “*” marked represents similar segmentation in other categories in the respective section.